Streetbeat News

Analyst Ratings

KIDS

Needham analyst Mike Matson has maintained a 'Buy' rating on OrthoPediatrics (NASDAQ:KIDS) but lowered the price target from $55 to $37.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 6:30 pm

VVX

RBC Capital analyst Ken Herbert has maintained an 'Outperform' rating on V2X (NYSE:VVX) but lowered the price target from $62 to $55.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 6:29 pm

SAFE

RBC Capital analyst Kenneth Lee has maintained an Outperform rating on Safehold (NYSE:SAFE) but lowered the price target from $38 to $33.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 6:27 pm

VRTX

RBC Capital analyst Brian Abrahams has maintained a 'Sector Perform' rating on Vertex Pharmaceuticals (NASDAQ:VRTX) and lowered the price target from $350 to $347.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 6:23 pm

OLO

RBC Capital analyst Matthew Hedberg maintains an Outperform rating on Olo (NYSE:OLO) but has lowered the price target from $11 to $9.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 6:21 pm

PRLD

HC Wainwright & Co. analyst Robert Burns maintains a 'Buy' rating on Prelude Therapeutics (NASDAQ:PRLD) but lowers the price target from $6 to $5.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 6:20 pm

UNIT

Bank of America has downgraded the stock of Uniti Group, leading to a drop in the company's shares.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 6:16 pm

GEL

RBC Capital analyst Elvira Scotto maintains an Outperform rating on Genesis Energy (NYSE:GEL) and raises the price target from $14 to $15.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 6:13 pm

EVCM

RBC Capital analyst Matthew Hedberg maintains an Outperform rating on EverCommerce (NASDAQ:EVCM) but lowers the price target from $14 to $12.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 6:11 pm

BMRN

RBC Capital analyst Luca Issi has reiterated a 'Sector Perform' rating on Biomarin Pharmaceutical (NASDAQ:BMRN) and maintained a $100 price target.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 6:09 pm